Yazeed Samara
Eisenhower Medical Center
20 Papers
5 Citations
Yazeed Samara is an academic researcher from Eisenhower Medical Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 4 publications. Previous affiliations of Yazeed Samara include University of California, Santa Cruz.
Chat about Author
Papers
Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
Joanna C. Zurko,Jeremy Ramdial,Mazyar Shadman,Saira Ahmed,A. Szabo,Lorenzo Iovino,Ana Alarcon Tomas,Craig S. Sauter,Miguel-Angel Perales,Nirav N. Shah,Utkarsh Acharya,Caron A. Jacobson,Robert J. Soiffer,Trent P Wang,Krishna V. Komanduri,Samantha Jaglowski,Adam Kittai,Nathan Denlinger,Madiha Iqbal,Mohamed A. Kharfan-Dabaja,Ernesto Ayala,Julio C. Chavez,Michael D. Jain,Frederick L. Locke,Yazeed Samara,Lihua E. Budde,Matthew Mei,Alexandra Della Pia,Ted Feldman,Nausheen Ahmed,Ryan Jacobs,Nilanjan Ghosh,Bhagirathbhai Dholaria,Olalekan O. Oluwole,Brian T. Hess,Ayesha A. Hassan,Vaishalee P. Kenkre,Patrick M. Reagan,Farrukh T. Awan,Yago Nieto,Mehdi Hamadani,Alex F. Herrera +41 more
TL;DR: A multicenter retrospective study assessing the safety, toxicities, and outcomes of alloHCT in LBCL patients following CAR-T failure finds that one-year overall survival, progression- free survival, and graft-versus-host disease-free relapse-free survival were 59, 45, and 39% respectively.
57
Acute autoimmune myocarditis and hepatitis due to ipilimumab monotherapy for malignant melanoma
TL;DR: A case of autoimmune myocarditis leading to biventricular failure after four doses of IV ipilimumab 3 mg/kg as a single agent is presented, suggesting this toxic effect may be anticipated with PD1 inhibitors.
24
Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?:
Constantin A Dasanu,Yazeed Samara,Ion Codreanu,Farhad M Limonadi,Omid Hamid,Juliana Alvarez-Argote +5 more
TL;DR: The scientific literature on systemic therapy options for relapsed, persistent or metastatic meningioma, not amenable to local therapy, is reviewed comprehensively and positive findings of two prospective phase II trials suggest a clinical benefit for the vascular endothelial growth factor inhibitor bevacizumab in refractory mening ioma.
16
Autologous Stem Cell Transplantation in Hodgkin Lymphoma—Latest Advances in the Era of Novel Therapies
Yazeed Samara,Matthew Mei +1 more
TL;DR: The current data regarding autoHCT in HL is surveyed with a focus on pre-autoHCT salvage as well as maintenance strategies, and the emerging data challenging the long-held dogma of chemosensitivity being a requirement for successfulAutoHCT is talked about.
A Case of Metastatic Gastric Leiomyosarcoma With Bilateral Adrenal Involvement and Complications
David Yashar,Ameish Govindarajan,Yazeed Samara,Jen-Jain Lee +3 more
TL;DR: This case illustrates a presentation of gastric leiomyosarcoma with bilateral adrenal involvement, the challenges in its diagnosis, treatment, as well as a rare complication of primary adrenal insufficiency and adrenal crisis.
4